The present disclosure relates to a microfluidic particle concentrator that includes an inlet microchannel, a filtering chamber fluidly connected to the inlet microchannel to receive a sample fluid, and a mechanical filter positioned in the filtering chamber. The particle concentrator also includes a filter outlet microchannel fluidly connected to the filtering chamber to receive a particle-ablated fluid formed by passing through the mechanical filter, a particle outlet microchannel fluidly connected to the filtering chamber to receive a particle-concentrated fluid including a plurality of particles not permitted to pass through the mechanical filter, and a fluid movement network including multiple pumps. The multiple fluid pumps generate sample fluid flow through the inlet microchannel and into the filtering chamber, particle-ablated fluid flow from the mechanical filter into the filter outlet microchannel, and particle-concentrated fluid from the filtering chamber into the particle outlet microchannel.

Disclosed are a sample analyzing method and a sample analyzer for measuring red blood cells and platelets. The method includes: preparing a first test sample solution containing a blood sample and a diluent; using an impedance method to acquire a first measurement result of red blood cells and platelets; when the first measurement result indicates that the blood sample is abnormal, preparing a second test sample solution containing the blood sample and a diluent or preparing a second test sample solution from the first test sample solution; irradiating the second test sample solution with light; collecting scattered light signals generated by particles in the second test sample solution; and acquiring a second measurement result of red blood cells and platelets in the second test sample solution based on the scattered light signals. Thus, RBC and PLT can be accurately classified especially under a condition of using an ordinary diluent.

The subject invention pertains to compositions of novel analogs of red blood cells that are distinguishable from white blood cells in a hematological instrument and processes for manufacturing such analogs. The processes for creating the compositions comprise washing, shrinking, and fixing cells at temperatures at or below room temperature.

The subject invention pertains to compositions of novel analogs of red blood cells that are distinguishable from white blood cells in a hematological instrument and processes for manufacturing such analogs. The processes for creating the compositions comprise washing, shrinking, and fixing cells at temperatures at or below room temperature.

Systems and methods for identifying Multisystem Inflammatory Syndrome in Children (MIS-C) may use various hematological parameters and combinations of hematological parameters. Such parameters and combinations may use monocyte distribution width (MVDW), though other parameters may also be used. Using this approach, area under curve values of 0.8 or greater may be achieved. Such parameters may also be used in treatment of MIS-C, including evaluation of status of hospitalized patients to determine when such patients may be safely discharged.

Systems and methods for identifying Multisystem Inflammatory Syndrome in Children (MIS-C) may use various hematological parameters and combinations of hematological parameters. Such parameters and combinations may use monocyte distribution width (MVDW), though other parameters may also be used. Using this approach, area under curve values of 0.8 or greater may be achieved. Such parameters may also be used in treatment of MIS-C, including evaluation of status of hospitalized patients to determine when such patients may be safely discharged.

Disclosed is a blood analyzer including: a first sample preparation unit configured to prepare, from a blood sample, a first measurement sample for measuring a red blood cell infected with malaria; a second sample preparation unit configured to prepare, from the blood sample, a second measurement sample for measuring intrinsic fluorescence of a red blood cell; a light source unit configured to apply light to the first and the second measurement samples; a detection unit configured to detect fluorescence and scattered light generated from the first measurement sample to which light has been applied, and detect intrinsic fluorescence generated from the second measurement sample to which light has been applied; and an information processing unit configured to generate information about malaria infection based on fluorescence and scattered light detected from the first measurement sample, and generate information about iron-deficiency anemia based on intrinsic fluorescence detected from the second measurement sample.

A method of controlling a blood analyzer for measuring platelets is provided. The method comprises: determining a relationship between at least one first measurement value obtained by detecting platelets in at least one previous test by an electrical type detector of the blood analyzer and at least one second measurement value obtained by detecting the platelets in the at least one previous test by an optical type detector of the blood analyzer, and controlling the blood analyzer to prepare the first and/or second measurement sample for a current test according to the determined relationship.

A method of controlling a blood analyzer for measuring platelets is provided. The method comprises: determining a relationship between at least one first measurement value obtained by detecting platelets in at least one previous test by an electrical type detector of the blood analyzer and at least one second measurement value obtained by detecting the platelets in the at least one previous test by an optical type detector of the blood analyzer, and controlling the blood analyzer to prepare the first and/or second measurement sample for a current test according to the determined relationship.

The objective of the present invention is to provide a particle detection device and a particle detection method that can individually and continuously detect a wide range of particles. The objective is achieved by a particle detection device including: a particle separation channel through which particles are separated according to particle sizes in a perpendicular direction to the flow of fluid; and two or more particle recovery channels that are connected to and branched from the particle separation channel, in which each of the particle recovery channels includes a particle detection unit that includes an aperture and an electric detector.